Introduction: Few studies have considered the factors independently associated with chronic fatigue syndrome (CFS) and/or fibromyalgia (FM) or considered the impact of these conditions on health status using population-based data.
Introduction
In 2003, about 1.3% of the adult Canadian population reported having chronic fatigue syndrome (CFS) and 1.5% reported having fibromyalgia (FM). 1 CFS, or myalgic encephalomyelitis, is characterized by persistent and profound physical and cognitive fatigue, whereas FM is characterized by chronic and widespread musculoskeletal pain. 2 In addition, these 2 conditions often co-occur. [1] [2] [3] [4] Co-occurrence of multiple chronic conditions in the same individual increases the costs and intensifies the use of health care resources 5, 6 and, as demonstrated in the context of other chronic conditions, can profoundly affect people's health-related quality of life. [6] [7] [8] [9] [10] A few studies in Canada 1,2 and elsewhere [11] [12] [13] have considered the impact of CFS and FM on health status. Lavergne et al. 2 showed that Canadian patients with CFS/ FM had poorer health status, measured using the Short Form-36, compared to the general Canadian population. In this tertiary care / referral clinic patient population, considered by the authors to be more impaired than other people of the same sex and age range with these disorders (e.g. people with CFS and/or FM selected as part of population-based surveys), lower functioning was associated with younger age at onset, lower socio-economic status, and CFS and FM coexisting. 2 Nonetheless, data from the national population-based 2003 Canadian Community Health Survey (CCHS) indicate that Canadians with CFS and FM report poorer general health and mental health, greater dissatisfaction with life, higher prevalence of mental illness, needing more assistance in the activities of daily living and using health care services more often. 1 These data also showed that being female, older, of lower income, and of lower educational attainment are associated with prevalent CFS 1 and FM. 1, 14 However, analyses did not consider whether these factors were independently associated with these conditions.
Using more recent data, from the 2010 CCHS, we sought to determine (1) the factors independently associated with having CFS and FM; (2) the impact of these conditions on health status; and (3) the factors associated with poorer health status among Canadians with these conditions.
Methods

Data source
We analyzed data from the 2010 CCHSAnnual Component Share File. The CCHS is a cross-sectional survey conducted by 
Analytical strategy
We developed our analytical strategy in 3 interrelated stages: (1) Covariates were identified a priori based on previous studies of CFS and FM, either using CCHS data 1, 14 ), alcohol consumption (weekly alcohol consumption, less than weekly and did not consume any alcohol in the past 12 months), smoking status (never, former, current), fruit and vegetable consumption (< 5 vs. § 5 servings/day) and physical activity (active, moderately active, inactive). The physical activity index is based on total estimated daily energy expenditure calculated from self-reported frequency and duration of leisure-time and transportation-related physical activities for the 3 months prior to the interview. 15 We also examined the presence of other chronic conditions. We defined comorbidity as the total number of other chronic conditions reported and categorized these in 2 groups: less than 3 versus 3 or more. This cut-off was determined based on the results of our bivariate analysis that showed that a feature of CFS and FM is that almost all of respondents with the conditions had at least 1 or 2 other chronic conditions. The chronic conditions included in the 2010 CCHS were asthma, arthritis, back problems, chronic obstructive pulmonary disease (COPD), bowel disorders, multiple chemical sensitivities, migraine, high blood pressure, heart disease, diabetes, cancer, stomach ulcer, urinary incontinence, mood disorder, anxiety disorder, Alzheimer or other dementia, amyotrophic lateral sclerosis, cerebral palsy, dystonia, epilepsy, hydrocephalus, Huntington disease, muscular dystrophy, multiple sclerosis, Parkinson disease, spina bifida, stroke, Tourette syndrome and neurological conditions caused by brain and/or spinal cord injury and/or tumour. N Fair/poor general and mental health.
We based general health and mental health status on the self-report items ''In general, would you say your health is: excellent, very good, good, fair, poor?'' and ''In general, would you say your mental health is: excellent, very good, good, fair, poor?'' We dichotomized the responses as fair/ poor versus excellent/very good/good for each respective question.
N Activity limitations. We derived a measure of the limitations in a respondent's daily activities based on the responses-often, sometimes or never-to a series of 5 questions: (1)''Do you have any difficulty hearing, seeing, communicating, walking, climbing stairs, bending, learning or doing any similar activities?'' and ''Does a long-term physical condition or mental condition or health problem reduce the amount or the kind of activity you can do... (2) N Help needed for tasks. We classified respondents as needing help for tasks if they reported requiring the help of another person to perform any 1 of 6 activities of daily living: preparing meals, getting to appointments/running errands, doing housework, personal care, moving about inside the house and looking after personal finances.
N Severe level of impairment. We measured health-related quality of life using the Health Utilities Index (HUI). The HUI health states are defined by 8 attributes (vision, hearing, speech, ambulation, dexterity, emotion, cognition, and pain and discomfort), with 5 or 6 levels of functioning for each attribute. A utility function is used to 
Statistical analysis
We analyzed data using SAS Enterprise Guide version 5.1 (SAS Institute Inc., Cary, NC, US). Significance was specified as a p value of less than 0.05 in all analyses. To account for sample allocation and survey design, all estimates were weighted using survey weights generated by Statistics Canada, and 95% confidence intervals (CI) were estimated using bootstrap resampling method. Associations were quantified using prevalence ratios (PRs) estimated using multivariate binomial regression, using an intercept of 24 to improve convergence. 16 
Results
Prevalence of CFS and FM
In 2010, about 411 000 (1.4%; 95% CI: 1.3%-1.6%) and 444 000 (1.5%; 95% CI: 1.4%-1.7%) of Canadians aged 12 years and older reported having been diagnosed with CFS and FM, respectively. About 0.3% (95% CI: 0.3%-0.4%) of the total household population reported having both conditions. Approximately 1 in 4 people with CFS (23.0%) also reported having FM, and 1 in 5 people with FM (21.2%) also reported having CFS. Overall, the prevalence of CFS and/or FM was higher in women across all age groups ( Figure 1 ).
Factors associated with prevalent CFS and FM
After adjusting for covariates, women, adults aged 40 years and over and those with the lowest income were more likely to report having been diagnosed with CFS or FM (Table 1 ). In addition, prevalent 
Impact of CFS and/or FM on health status
Canadians with CFS and/or FM reported having indicators of poor health status more commonly than did Canadians with neither of these conditions (Table 2) . After controlling for differences in the number of other chronic conditions, sociodemographics and health risk factors, people with CFS and/or FM were 1.2 to 1.9 times more likely to report poor health status (5 indicators) compared to those without these conditions ( found that 50% discontinued their employment due to symptoms related to CFS. The authors estimated that CFS cost the UK economy £75 to £129 million in lost $ productivity. 18 Similarly, Reynolds et al. 19 estimated a 37% decline in household productivity and a 54% reduction in labour force productivity as a result of CFS. The annual total value of lost productivity in the United States was about $9.1 billion or $20 000 per person with CFS. Knight et al. 20 estimated that FM costs the US economy $7333 per patient in lost productivity due to disability and $1228 per patient in lost productivity due to absenteeism. Thus, inability to work or reduced work time due to CFS or FM may affect income, as opposed to lower income being a determinant of these conditions.
We also showed, consistent with findings from the 2000-2001 CCHS, 14 that lifestyle risk factors for chronic disease (i.e. obesity, physical inactivity and smoking) were associated with CFS and/or FM, but again the direction of the relationship is unclear given the cross-sectional nature of the data. In the current analysis, people who were obese were 1.5 times more likely to report having FM. Ursini et al. 21 hypothesized a number of mechanisms linking FM and obesity including reduced physical activity, sleep disturbances, depression, thyroid dysfunction, and hormonal disturbances involving the deregulation of insulin-like growth factor.
In our analysis, self-reported physical inactivity was related to reporting a diagnosis of CFS. Using data from the prospective 1958 National Child Development Study birth cohort in England, Wales, and Scotland, Goodwin et al. 22 showed that weekly physical activity at age 23 and 33 years was unrelated to the development of CFS by the age of 42 years. This lack of correlation is in contrast to the finding from the 1946 birth cohort in these same countries that showed more frequent exercise in childhood and early adulthood predicted CFS by the age of 53 years. 23 Although only 2 prospective studies, to our knowledge, have examined this relationship, these findings suggest that physical inactivity is more likely a consequence of CFS than a cause. Physical inactivity may arise from greater physical impairment, fatigue and pain in CFS and FM, and was associated with these factors in our analysis.
Our study found that former and current smoking was also related to CFS; to our knowledge no study has prospectively considered whether smoking is a risk factor for CFS.
Comorbidity, whether having both CFS and FM or having other chronic conditions in addition to CFS or FM, is a central issue in the population examined in this study. Other studies have shown that patients diagnosed with both FM and CFS reported a worse disease course, worse overall health, greater dissatisfaction with health and greater disease impact than those with CFS or FM alone. 2, 24 Our results also show that a person's level of comorbidity may substantially affect their health status outcomes. In addition, 2 out of 3 people with CFS and/or FM reported at least 3 other chronic conditions. Our analysis showed that the number of concurrent health conditions among those with CFS and/or FM largely accounted for much of 
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Strengths and limitations
Our study is strengthened by our use of a large, population-based survey of the Canadian population living in the community, with a good response rate. The CCHS provides comprehensive data on descriptive variables, enabling in-depth analysis of the health status of people living with CFS and FM as well as allowing comparisons with different subgroups. The CCHS relies on self-reporting of chronic conditions and health events. While it is the most practical method of assessing disease status in large population studies, self-reporting of diagnosis is susceptible to misclassification, resulting in potential under-or over-estimation of disease prevalence and societal burden. In our study, CCHS respondents self-reported their disease history (including the diagnosis of CFS and/or FM), and there was no third-party corroboration or verification of these self-reports. Research has found acceptable to good agreement between self-reported physical health conditions and diagnoses made by medical professionals, 25 but validation of self-reported CFS and FM in particular has not, to our knowledge, been specifically undertaken. Studies of diagnostic practices, focussing on the case definition used by health professionals in diagnosing CFS/FM, are scarce and have yet to be done in Canada.
As previously acknowledged, the crosssectional design of the survey does not allow the examination of possible causal pathways or mechanisms, so it is unclear whether the associations we found with lifestyle risk behaviours could be viewed as (a) risk factors for developing the conditions or (b) a result of the condition. Etiological studies (such as case-control or cohort studies) are required to determine whether, in the context of CFS and FM, these represent potential preventable risk factors or not. Finally, while we have included in our analytical strategy the important covariates identified in the CFS and FM literature, our analysis was restricted to the set of variables collected by the CCHS. This may have precluded the inclusion of other important covariates that may have been confounders of the associations we examined in this study, such as disease severity or duration of illness.
Conclusion
We found that, in 2010, CFS and FM were reported by approximately 1.4% and 1.5%, respectively, of the Canadian household population 12 years of age and older. We observed that prevalent CFS and FM were related to female sex, adults 40 years and older and lifestyle risk factors for chronic diseases, although the reasons behind these associations are unclear. These findings may warrant further research to examine whether these lifestyle risk factors are part of the causal pathway or are the effects of the conditions. Co-occurrence of CFS and FM and having other diagnosed chronic conditions were strongly related to poorer health status and accounted for much of the differences in health status. Comorbidity as a driving force behind poorer health status cannot be ignored.
Given the relative paucity of data on CFS and FM, these results from a community-based survey are relevant to the field of public health. They reinforce prior findings that these conditions frequently co-occur with a range of other diseases. Because CFS or FM without comorbidities is actually rare, researchers and clinicians can anticipate substantial complexity in their studies and clinical care. In particular, research that does not exclude patients with comorbidities would be most relevant to health professionals and public health practitioners. Finally, understanding the factors that contribute to improved quality of life in people with CFS and/or FM, particularly in those with both conditions and other comorbidities, may be an important area for future research. 
